These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6534272)

  • 21. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from he kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 5. Preclinical evaluation of the urinary NAG activity and its fluctuations in kidney and liver diseases and diabetes mellitus].
    Kin K; Akiyoshi R; Ohashi M; Nihonyanagi Y
    Rinsho Byori; 1983 Sep; Spec No 56():102-10. PubMed ID: 6663751
    [No Abstract]   [Full Text] [Related]  

  • 22. [Urinary N-acetyl-beta-glucosaminidase as index of renal toxicity (author's transl)].
    Oudart N; Marcher K; Lacour B; Boulu RG; Guichard C
    Toxicol Eur Res; 1981 May; 3(3):149-51. PubMed ID: 7281165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical evaluation of urinary n-acetyl-beta-d-glucosaminidase activity in patients treated with aminoglycosides].
    Hirokawa N; Naruse T
    Nihon Jinzo Gakkai Shi; 1982 Sep; 24(9):1041-53. PubMed ID: 7161951
    [No Abstract]   [Full Text] [Related]  

  • 24. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 10. Clinical significance of urinary NAG activity in patients with kidney diseases, with special reference to nephrotic syndrome and antibiotic treatment].
    Ishimoto F; Shibazaki T; Murai S; Kodama K; Ohno I; Gomi H
    Rinsho Byori; 1983 Sep; Spec No 56():147-59. PubMed ID: 6663756
    [No Abstract]   [Full Text] [Related]  

  • 25. [Excretion of N-acetyl-beta-glucosaminidase in patients treated with ifosfamide].
    Beretta R; Damiani E; Crippa S; Bertolini A; Ottolenghi L; Luchini S
    G Ital Chemioter; 1985; 32(1):39-42. PubMed ID: 3830792
    [No Abstract]   [Full Text] [Related]  

  • 26. Analysis of urinary N-acetyl-beta-D-glucosaminidase isozyme in patients treated with gentamicin or cis-diammine dichloroplatinum (II).
    Aikawa A; Hata M; Nakamura H
    Dev Toxicol Environ Sci; 1986; 14():183-6. PubMed ID: 3829974
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antineoplastic therapy and urinary enzymes. Preliminary note on the determination of urinary N-acetyl-beta-D-glucosaminidase in patients treated with cisplatin].
    Crovato E; Salvini R
    Boll Soc Ital Biol Sper; 1984 Dec; 60(12):2255-60. PubMed ID: 6543318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 2. Preclinical determination of the urinary NAG activities and the test data of patients admitted for multiphasic screening].
    Kiyose H; Tomii M; Shimomura H; Mizuno E; Taguchi I; Inoue Y
    Rinsho Byori; 1983 Sep; Spec No 56():73-8. PubMed ID: 6663763
    [No Abstract]   [Full Text] [Related]  

  • 29. [Determination of N-acetyl-beta-D-glucosaminidase activity of the urine using colorimetric and fluorimetric assay].
    Jung K; Nesener E
    Z Med Lab Diagn; 1988; 29(5):254-62. PubMed ID: 3223017
    [No Abstract]   [Full Text] [Related]  

  • 30. [N-acetyl-beta-D-glucosaminidase: a sensible enzyme to functional and morphologic renal changes].
    Kopf SR; Nahmod VE
    Medicina (B Aires); 1988; 48(2):215-6. PubMed ID: 3231086
    [No Abstract]   [Full Text] [Related]  

  • 31. [Dosage of N-acetyl-beta-D glucosaminidase in the surveillance of nephrotoxic antibiotic treatment. Preliminary results].
    Dupond JL; Leconte des Floris R; Gibey R; Henry JC
    Nouv Presse Med; 1977 May; 6(21):1881-2. PubMed ID: 876838
    [No Abstract]   [Full Text] [Related]  

  • 32. [Study on N-acetyl-beta-glucosaminidase (NAG) activity in urine. I. Methodological study and normal values].
    Uno E; Sano K
    Rinsho Byori; 1983 Dec; 31(12):1325-9. PubMed ID: 6676486
    [No Abstract]   [Full Text] [Related]  

  • 33. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 1. Description of NAG activity determination].
    Noto A; Mori S; Nakamura M; Kitakaze T
    Rinsho Byori; 1983 Sep; Spec No 56():65-72. PubMed ID: 6663762
    [No Abstract]   [Full Text] [Related]  

  • 34. [Study on N-acetyl-beta-glucosaminidase (NAG) activities in the urine. II. The relation between NAG activities and various renal function tests in renal diseases].
    Uno E; Sano K
    Rinsho Byori; 1984 Apr; 32(4):419-24. PubMed ID: 6471495
    [No Abstract]   [Full Text] [Related]  

  • 35. [The excretion of N-acetyl-beta-D-glucosaminidase in the urine of children with urinary tract diseases].
    Zandvliet EE; Giesberts MA; van Gelderen HH
    Tijdschr Kindergeneeskd; 1983 Aug; 51(4):135-8. PubMed ID: 6670088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative study of the diagnostic value of disc electrophoresis of urinary proteins and measurement of the excretion of N-acetylglucosaminidase for the detection of renal tubule damage in chronic polyarthritis (author's transl)].
    Knoll E; Wisser H; Rautenstrauch H
    J Clin Chem Clin Biochem; 1980 Jan; 18(1):53-8. PubMed ID: 7359091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Spectrophotometric evaluation of N-acetyl-beta-glucosaminidase in urine].
    Potere C; Di Cosmo C; Riario-Sforza G; Di Silverio F; Albertazzi A; Cappelli P
    Arch Sci Med (Torino); 1982; 139(4):409-16. PubMed ID: 7168631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical evaluation of urinary N-acetyl-beta-D-glucosaminidase activity in patients receiving aminoglycoside and cephalosporin drugs.
    Naruse T; Hirokawa N; Oike S; Maekawa T
    Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):313-29. PubMed ID: 7221185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Renal excretion of N-acetyl-beta-D-hexosaminidase and its isoforms after allotransplantation of cadaver kidneys].
    Tomilina NA; Vafina MG; Fedorova ND
    Urol Nefrol (Mosk); 1984; (5):51-7. PubMed ID: 6390919
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of N-acetyl-beta-glucosaminidase in two groups of renal transplant recipients undergoing conventional and cyclosporin A therapy: 48 months follow-up.
    Montanari A; Briganti M; Cocchi R; Emiliani G; Fabbri A; Mandreoli M; Fusaroli M
    Dev Toxicol Environ Sci; 1986; 14():135-40. PubMed ID: 3549245
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.